AgomAb Therapeutics NV (AGMB) Operating Expenses (2025)
Agomab Therapeutics (AGMB) reported Operating Expenses of -$69.67 million for FY2025, compared with -$53.51 million in FY2024.
Powered by 
Analysis
AgomAb Therapeutics NV (AGMB) Operating Expenses (2025) Analysis & Trends
- According to Business Quant data, Operating Expenses came in at -$53.51 million in FY2024 and -$35.06 million in FY2023.
Peer Set
Peer Comparison
API Access
AgomAb Therapeutics NV Operating Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-expenses&ticker=AGMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-expenses", "ticker": "AGMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-expenses&ticker=AGMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();